← Back
$INO All transactions

INOVIO PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

105,262

Price

$0

Filed

May 21

Insider

Name

Shea Jacqueline Elizabeth

Title

Chief Executive Officer

CIK

0001771498

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

105,262

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. | The vesting schedule for the 105,262 options is as follows: 52,631 shares will vest on May 20, 2027 and 52,631 shares will vest on May 20, 2028.

Filing Info

Accession No.

0001055726-25-000042

Form Type

4

Issuer CIK

0001055726

Shea Jacqueline Elizabeth's History

Date Ticker Type Value
2025-05-20 INO A $0
2025-05-20 INO A $0
2025-05-15 INO M
2025-05-15 INO F $15K
2025-05-15 INO M $0
2025-05-10 INO M
2025-05-10 INO F $4K
2025-05-10 INO M $0

Other Insiders at INO (90d)

Insider Bought Sold Last
Sumner Michael John
Chief Medical Officer
2026-03-31